Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2012 3
2013 2
2015 2
2016 2
2018 2
2020 4
2021 5
2022 5
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Rituximab-induced coagulopathy.
Novak J, Mocikova H, Pavlicek P, Gaherova L, Kozak T. Novak J, et al. Among authors: pavlicek p. Leuk Lymphoma. 2012 Nov;53(11):2299-301. doi: 10.3109/10428194.2012.682313. Epub 2012 May 16. Leuk Lymphoma. 2012. PMID: 22480246 Review. No abstract available.
Daratumumab with lenalidomide and dexamethasone in relapsed or refractory multiple myeloma patients - real world evidence analysis.
Stork M, Spicka I, Radocha J, Minarik J, Jelinek T, Jungova A, Pavlicek P, Pospisilova L, Sedlak F, Straub J, Pika T, Knechtova Z, Fidrichova A, Boichuk I, Sevcikova S, Maisnar V, Hajek R, Pour L. Stork M, et al. Among authors: pavlicek p. Ann Hematol. 2023 Jun;102(6):1501-1511. doi: 10.1007/s00277-023-05188-4. Epub 2023 Apr 24. Ann Hematol. 2023. PMID: 37088816 Free PMC article.
Limited efficacy of daratumumab in multiple myeloma with extramedullary disease.
Jelinek T, Sevcikova T, Zihala D, Popkova T, Kapustova V, Broskevicova L, Capkova L, Rihova L, Bezdekova R, Sevcikova S, Zidlik V, Havel M, Plonkova H, Jungova A, Minarik J, Stork M, Pour L, Pavlicek P, Spicka I, Maisnar V, Radocha J, Simicek M, Hajek R. Jelinek T, et al. Among authors: pavlicek p. Leukemia. 2022 Jan;36(1):288-291. doi: 10.1038/s41375-021-01343-w. Epub 2021 Jul 10. Leukemia. 2022. PMID: 34247197 No abstract available.
Unexpected Heterogeneity of Newly Diagnosed Multiple Myeloma Patients with Plasmacytomas.
Stork M, Sevcikova S, Jelinek T, Minarik J, Radocha J, Pika T, Pospisilova L, Spicka I, Straub J, Pavlicek P, Jungova A, Knechtova Z, Sandecka V, Maisnar V, Hajek R, Pour L. Stork M, et al. Among authors: pavlicek p. Biomedicines. 2022 Oct 11;10(10):2535. doi: 10.3390/biomedicines10102535. Biomedicines. 2022. PMID: 36289797 Free PMC article.
Identification of patients at high risk of secondary extramedullary multiple myeloma development.
Stork M, Sevcikova S, Minarik J, Krhovska P, Radocha J, Pospisilova L, Brozova L, Jarkovsky J, Spicka I, Straub J, Pavlicek P, Jungova A, Jelinek T, Sandecka V, Maisnar V, Hajek R, Pour L. Stork M, et al. Among authors: pavlicek p. Br J Haematol. 2022 Feb;196(4):954-962. doi: 10.1111/bjh.17925. Epub 2021 Nov 2. Br J Haematol. 2022. PMID: 34726261 Free PMC article.
Clinical characteristics and outcomes in risk-stratified patients with smoldering multiple myeloma: data from the Czech Republic Registry of Monoclonal Gammopathies.
Sandecka V, Popkova T, Stork M, Maisnar V, Minarik J, Jungova A, Pavlicek P, Stejskal L, Pospisilova L, Heindorfer A, Obernauerova J, Gregora E, Sykora M, Ullrychova J, Wrobel M, Kessler P, Jelinek T, Kunovszki P, Bathija S, Gros B, Wilbertz S, Cai Q, Lam A, Spicka I. Sandecka V, et al. Among authors: pavlicek p. Blood Cancer J. 2023 Sep 27;13(1):153. doi: 10.1038/s41408-023-00906-7. Blood Cancer J. 2023. PMID: 37752128 Free PMC article.
Various phenotypes of disease associated with mutated DGKE gene.
Bezdíčka M, Pavlíček P, Bláhová K, Háček J, Zieg J. Bezdíčka M, et al. Among authors: pavlicek p. Eur J Med Genet. 2020 Aug;63(8):103953. doi: 10.1016/j.ejmg.2020.103953. Epub 2020 May 13. Eur J Med Genet. 2020. PMID: 32413569
Real-world evidence of efficacy and safety of pomalidomide and dexamethasone in relapsed/refractory multiple myeloma patients: Czech registry data.
Sandecka V, Pour L, Špička I, Minařík J, Radocha J, Jelínek T, Pavlíček P, Jungová A, Kessler P, Wróbel M, Štork M, Štraub J, Pika T, Čápková L, Ševčíková S, Maisnar V, Hájek R. Sandecka V, et al. Among authors: pavlicek p. Neoplasma. 2022 Dec;69(6):1474-1479. doi: 10.4149/neo_2022_220813N827. Neoplasma. 2022. PMID: 36591805
Urine immunofixation negativity is not necessary for complete response in intact immunoglobulin multiple myeloma: Retrospective real-world confirmation.
Radocha J, Jelinek T, Pour L, Spicka I, Minarik J, Popkova T, Jungova A, Pavlicek P, Brozova L, Stork M, Sedlak F, Krhovska P, Maisnar V, Heindorfer A, Sykora M, Wrobel M, Mikula P, Kessler P, Ullrychova J, Hajek R. Radocha J, et al. Among authors: pavlicek p. Int J Lab Hematol. 2021 Oct;43(5):e244-e247. doi: 10.1111/ijlh.13460. Epub 2021 Jan 16. Int J Lab Hematol. 2021. PMID: 33452712 No abstract available.
25 results